Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asbill

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Hospital Practice (Office Ed.)|May 30, 1986
Two gay patients with demyelinating disordersM C Asbill, P Z Marmarelis, P K Brownstone
Critical Reviews in Therapeutic Drug Carrier Systems|February 24, 2001
Enhancement of transdermal drug delivery: chemical and physical approachesC S Asbill, A F El-Kattan, B Michniak
Hospital Practice (Office Ed.)|September 1, 1984
A Jehovah's Witness with thrombocytopeniaM C Asbill, R A Wallis, F A Apgar
Hospital Practice (Office Ed.)|July 1, 1984
Hypercalcemia, nausea, years of bloody diarrheaM C Asbill, K Rocha-Singh, E J Jacobson
International Journal of Pharmaceutical Compounding|August 24, 2013
Isoniazid release from suppositories compounded with selected basesKristofer C Hudson, C Scott Asbill, Andrew A Webster
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1985
Indium-111 leukocyte imaging in colitis induced by Clostridium difficileM C Asbill, F Shanahan, G M Van Deventer
International Journal of Pharmaceutics|April 18, 2000
The effect of terpene enhancer lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel systemsA F El-Kattan, C S Asbill, B B Michniak
International Journal of Pharmaceutical Compounding|September 20, 2013
Effect of formulation pH on transdermal penetration of antiemetics formulated in poloxamer lecithin organogelRachel Woodall, John J Arnold, Doug McKay, et al.
International Journal of Pharmaceutical Compounding|April 11, 2024
Compounded Pain Formulations: What is the Evidence?Scott Asbill, Sarah M Sweitzer, Shuler Spigener, et al.
International Journal of Pharmaceutical Compounding|December 6, 2014
Compounded pain formulations: what is the evidence?Scott Asbill, Sarah M Sweitzer, Shuler Spigener, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Hospital Practice (Office Ed.)|May 30, 1986
Two gay patients with demyelinating disordersM C Asbill, P Z Marmarelis, P K Brownstone
Critical Reviews in Therapeutic Drug Carrier Systems|February 24, 2001
Enhancement of transdermal drug delivery: chemical and physical approachesC S Asbill, A F El-Kattan, B Michniak
Hospital Practice (Office Ed.)|September 1, 1984
A Jehovah's Witness with thrombocytopeniaM C Asbill, R A Wallis, F A Apgar
Hospital Practice (Office Ed.)|July 1, 1984
Hypercalcemia, nausea, years of bloody diarrheaM C Asbill, K Rocha-Singh, E J Jacobson
International Journal of Pharmaceutical Compounding|August 24, 2013
Isoniazid release from suppositories compounded with selected basesKristofer C Hudson, C Scott Asbill, Andrew A Webster
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1985
Indium-111 leukocyte imaging in colitis induced by Clostridium difficileM C Asbill, F Shanahan, G M Van Deventer
International Journal of Pharmaceutics|April 18, 2000
The effect of terpene enhancer lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel systemsA F El-Kattan, C S Asbill, B B Michniak
International Journal of Pharmaceutical Compounding|September 20, 2013
Effect of formulation pH on transdermal penetration of antiemetics formulated in poloxamer lecithin organogelRachel Woodall, John J Arnold, Doug McKay, et al.
International Journal of Pharmaceutical Compounding|April 11, 2024
Compounded Pain Formulations: What is the Evidence?Scott Asbill, Sarah M Sweitzer, Shuler Spigener, et al.
International Journal of Pharmaceutical Compounding|December 6, 2014
Compounded pain formulations: what is the evidence?Scott Asbill, Sarah M Sweitzer, Shuler Spigener, et al.
Pageof 4